Introduction to Nootropic Peptides
Selank and semax represent two of the most extensively studied neuropeptides in cognitive enhancement and neuroprotection research. Both were developed at the Institute of Molecular Genetics of the Russian Academy of Sciences over several decades of systematic work on endogenous regulatory peptides. Remarkably, both have achieved regulatory approval in Russia as prescription medications — selank as an anxiolytic and semax as a nootropic and neuroprotective agent — making them among the very few synthetic peptides with established clinical use in any country.
Despite sharing institutional origins and the common structural feature of a Pro-Gly-Pro C-terminal extension (which enhances enzymatic stability), selank and semax operate through fundamentally different molecular mechanisms and produce distinct neurological profiles. Understanding these differences is essential for selecting the appropriate compound for specific cognitive or neuroprotective research questions.
Selank: Structure and Molecular Mechanism
Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic heptapeptide analog of tuftsin, an endogenous immunomodulatory tetrapeptide (Thr-Lys-Pro-Arg) derived from the Fc region of immunoglobulin G. The addition of the Pro-Gly-Pro tripeptide extension to tuftsin's C-terminus dramatically enhanced metabolic stability and introduced potent anxiolytic and nootropic properties not observed with native tuftsin. Selank has a molecular weight of approximately 751 Da.
Selank's neurological effects arise from several distinct but interconnected mechanisms.
GABAergic Modulation. Selank increases the binding affinity of GABA at GABA-A receptors, the primary inhibitory receptors in the central nervous system. GABA-A receptors are ligand-gated chloride channels: when GABA binds, chloride influx hyperpolarizes the neuron, reducing its excitability. By enhancing GABA-A binding, selank promotes inhibitory neurotransmission in limbic structures (amygdala, hippocampus) and cortical circuits involved in anxiety processing. Critically, this GABAergic modulation produces anxiolytic effects without the sedation, cognitive impairment, tolerance development, or dependence risk associated with benzodiazepines, which also target GABA-A receptors but through a different binding site and mechanism.
BDNF Expression. Selank significantly increases the expression of brain-derived neurotrophic factor (BDNF) in the hippocampus and prefrontal cortex. BDNF is a member of the neurotrophin family and plays a critical role in synaptic plasticity — the ability of synapses to strengthen or weaken in response to activity, which underlies learning and memory formation. BDNF activates TrkB receptors, triggering downstream MAPK/ERK, PI3K/Akt, and PLC-gamma signaling cascades that promote dendritic growth, spine formation, long-term potentiation (LTP), and neuronal survival. The BDNF-enhancing effect of selank is considered central to its nootropic properties.
Enkephalin System Modulation. Selank inhibits enzymes responsible for the degradation of enkephalins, endogenous opioid peptides (Met-enkephalin and Leu-enkephalin) that modulate pain perception, stress responses, and emotional states. By extending the half-life of enkephalins, selank enhances their anxiolytic and mood-regulating effects. This mechanism is distinct from direct opioid receptor agonism and does not produce the reinforcing effects, respiratory depression, or tolerance development associated with exogenous opioids.
Gene Expression Effects. Microarray studies in rat hippocampus revealed that selank influences the expression of 84 genes, with notable upregulation of genes involved in GABAergic neurotransmission, neurotrophic signaling, and immune regulation, and downregulation of genes associated with inflammatory signaling and oxidative stress. This broad transcriptional fingerprint suggests that selank's effects emerge from coordinated changes in multiple neurological pathways rather than a single target interaction.
Immunomodulatory Properties. Consistent with its origin as a tuftsin analog, selank retains immunomodulatory properties. It modulates cytokine expression profiles, enhances natural killer cell activity, and influences T-cell differentiation. These immune effects may be relevant to neuroinflammation-related cognitive decline and mood disorders where neuroimmune interactions play a pathogenic role.
Semax: Structure and Molecular Mechanism
Semax is a synthetic decapeptide consisting of the ACTH(4-10) fragment (Met-Glu-His-Phe-Pro-Gly-Pro) with the same Pro-Gly-Pro C-terminal extension used in selank. ACTH(4-7) was identified decades ago as the minimal fragment of adrenocorticotropic hormone retaining nootropic activity independent of adrenal steroidogenic effects. The Pro-Gly-Pro extension increased metabolic stability by 100-fold compared to the unmodified ACTH fragment. Semax has a molecular weight of approximately 813 Da.
Semax operates through mechanisms distinct from selank.
Neurotrophic Factor Induction. Semax is one of the most potent known inducers of BDNF and nerve growth factor (NGF) expression in the hippocampus and cerebral cortex. Single-dose administration produces sustained increases in BDNF mRNA and protein levels lasting 24 hours or longer. NGF, which supports the survival and function of cholinergic neurons in the basal forebrain (critical for attention and memory), is also significantly upregulated. The neurotrophic effects of semax are generally more pronounced than those of selank, particularly for NGF induction.
Melanocortin System Activation. As an ACTH fragment, semax retains activity at melanocortin receptors, particularly MC3R and MC4R, which are expressed in brain regions involved in learning, memory consolidation, and attention. MC4R activation in the hippocampus enhances LTP and memory formation, while MC3R activation in the cortex influences attention and executive function. This melanocortin mechanism is entirely absent from selank's pharmacology and represents a unique feature of semax.
Dopaminergic and Serotonergic Modulation. Semax modulates the metabolism and turnover of both dopamine and serotonin in key brain regions. It increases dopaminergic activity in the prefrontal cortex (relevant to attention, working memory, and executive function) and modulates serotonergic tone in limbic structures. These monoaminergic effects contribute to semax's activating, attention-enhancing profile and distinguish it from selank's calming profile.
Neuroprotective Effects. In models of cerebral ischemia (stroke), semax has demonstrated significant neuroprotective activity, reducing infarct volume, preserving neuronal viability, and improving functional recovery. Proposed mechanisms include neurotrophic support (BDNF and NGF maintain neuronal survival under ischemic stress), anti-inflammatory effects (reduced microglial activation and pro-inflammatory cytokine release), and antioxidant enzyme induction.
Comparison: Selank vs Semax
The two peptides produce complementary but distinct neurological profiles. Selank is best characterized as an anxiolytic-nootropic: it reduces anxiety through GABAergic and enkephalinergic mechanisms while enhancing cognitive function through BDNF upregulation. Its overall effect is calming with improved clarity and reduced stress reactivity. Semax is best characterized as a stimulating-nootropic: it enhances attention, focus, and cognitive processing through melanocortin receptor activation and dopaminergic modulation, with potent neurotrophic support from robust BDNF and NGF induction.
Both peptides increase BDNF, but through different upstream mechanisms — selank through GABAergic circuit modulation affecting activity-dependent BDNF release, and semax through direct transcriptional upregulation via melanocortin signaling. Both share the Pro-Gly-Pro stability-enhancing modification. Neither produces tolerance, dependence, or significant adverse effects in published studies.
Practical Research Notes
Both compounds are available from MiPeptidos as lyophilized powders at 99%+ HPLC purity. The Pro-Gly-Pro C-terminal extensions enhance enzymatic stability compared to their parent sequences. Store lyophilized at -20°C. Reconstitute with bacteriostatic water and store at 2–8°C.
Disclaimer
For research purposes only. Not for human consumption.